HomeNDC LookupRxCUI directory › RxCUI 1014580

12 HR cetirizine hydrochloride 5 MG / pseudoephedrine hydrochloride 120 MG Extended Releas... — RxCUI 1014580

RxNorm drug concept · Semantic branded drug
RxCUI 1014580 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1014580
Official name12 HR cetirizine hydrochloride 5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Wal Zyr D]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asWal Zyr D (cetirizine dihydrochloride 5 MG / pseudoephedrine hydrochloride 120 MG) 12 HR Extended Release Oral Tablet; WAL-ZYR D ALLERGY & CONGESTION 5 MG / 120 MG 12HR Extended Release Oral Tablet
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cetirizine Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Zerviate is an antihistamine eye drop that treats itchy eyes caused by allergic conjunctivitis — basically, eye allergies. It works right where you need it, blocking the itch signa...
  • You need to take your contacts out first. The preservative in Zerviate can get soaked up by soft contact lenses, which isn't good for your eyes. After you put the drops in, wait at...
  • Can I put my contact lenses in before or after using these drops?
  • The most common ones are eye redness, a brief sting or pain when the drop goes in, and slightly blurry vision right after. These are usually mild and short-lived. If you notice wor...
📖 Read our full Cetirizine Ophthalmic guide →

🕸️ Concept Web — How 12 HR cetirizine hydrochloride 5 MG / pseudoephe... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 12 HR cetirizine hydrochloride 5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Wal Zyr D] RxCUI 1014580

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Cetirizine 20610
    • Pseudoephedrine 8896
    • Cetirizine / pseudoephedrine 352367
    • Cetirizine hydrochloride 203150
    • Pseudoephedrine hydrochloride 91168
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Wal Zyr D 977496
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cetirizine / pseudoephedrine Extended Release Oral Tablet 378711
    • Cetirizine hydrochloride / pseudoephedrine hydrochloride Extended Release Oral Tablet 2646764
    • Cetirizine / pseudoephedrine Oral Product 1152443
    • Cetirizine / pseudoephedrine Pill 1152444
    • Cetirizine hydrochloride / pseudoephedrine hydrochloride Oral Product 2660489
    • Cetirizine hydrochloride / pseudoephedrine hydrochloride Pill 2660766
    • Cetirizine / pseudoephedrine Extended Release Oral Tablet [Wal Zyr D] 977498
    • Cetirizine hydrochloride / pseudoephedrine hydrochloride Extended Release Oral Tablet [Wal Zyr D] 2657994
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 12 HR cetirizine hydrochloride 5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet SCD · 1014571
  • Cetirizine hydrochloride 5 MG SCDC · 1014570
  • Pseudoephedrine hydrochloride 120 MG SCDC · 997405
  • Cetirizine / pseudoephedrine Extended Release Oral Tablet SCDF · 378711
  • Cetirizine hydrochloride / pseudoephedrine hydrochloride Extended Release Oral Tablet SCDFP · 2646764
  • Cetirizine / pseudoephedrine Oral Product SCDG · 1152443
  • Cetirizine / pseudoephedrine Pill SCDG · 1152444
  • Cetirizine hydrochloride / pseudoephedrine hydrochloride Oral Product SCDGP · 2660489
  • Cetirizine hydrochloride / pseudoephedrine hydrochloride Pill SCDGP · 2660766

Brand-Name Concepts

  • Cetirizine hydrochloride 5 MG / pseudoephedrine hydrochloride 120 MG [Wal Zyr D] SBDC · 1014579
  • Cetirizine / pseudoephedrine Extended Release Oral Tablet [Wal Zyr D] SBDF · 977498
  • Cetirizine hydrochloride / pseudoephedrine hydrochloride Extended Release Oral Tablet [Wal Zyr D] SBDFP · 2657994
  • Wal Zyr D Oral Product SBDG · 1187609
  • Wal Zyr D Pill SBDG · 1187610
  • Wal Zyr D BN · 977496

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1014580 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-0989-12 2 BLISTER PACK in 1 CARTON (0363-0989-12) / 6 TABLET, FILM... Wal-Zyr D Walgreen Company 2018-11-01
00363-0989-24 4 BLISTER PACK in 1 CARTON (0363-0989-24) / 6 TABLET, FILM... Wal-Zyr D Walgreen Company 2018-11-01
Observed labelers: Walgreen Company (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.